Brain 'Organoid' Study Hints at the Origins of Autism
Medically reviewed by Drugs.com.
By Cara Murez HealthDay Reporter
FRIDAY, Aug. 11, 2023 -- Research using three-dimensional replicas of the developing brain created in a lab dish is shedding new light on autism spectrum disorder.
Yale researchers found two paths to autism in the developing brain.
“It’s amazing that children with the same symptoms end up with two distinct forms of altered neural networks," co-senior author Dr. Flora Vaccarino said in a university news release. She is director of the program in neurodevelopment and regeneration at the Child Study Center at Yale School of Medicine in New Haven, Conn.
These abnormalities, which arise just weeks after the start of brain development, have been associated with the emergence of autism, according to the new research.
They seem to be dictated by the size of the child’s brain, the scientists said. That discovery may help to diagnose and treat autism in the future.
Researchers collected stem cells from 13 boys diagnosed with autism to create the brain organoids, which are lab-grown replicas of the developing brain that mimic neuronal growth in the fetus.
Patients were recruited from clinicians at the Yale Child Study Center.
Eight of the boys had a condition in which the head is enlarged, called macrocephaly.
About 20% of autism cases are in people with macrocephaly, in which the newborn's head size is in the 90th percentile or greater. These tend to be more severe autism cases.
Children with autism and macrocephaly exhibited excessive growth of excitatory neurons compared with their fathers, according to the study authors. The organoids of other children with autism had a deficit of the same type of neurons.
Excitatory neurons, which cause messages to be fired off in the brain, play a key role in functions like thinking, learning and memory, according to the Cleveland Clinic.
The ability to track the growth of these specific neurons could help doctors diagnose autism, researchers said. Symptoms of autism typically appear 18 to 24 months after birth.
Vaccarino said these findings may help identify autism cases that would benefit from existing drugs used to reduce symptoms of other disorders that involve excessive excitatory neuron activity, such as epilepsy. While autism patients with macrocephaly might benefit from these medications, those without enlarged brains may not.
Creating biobanks of patient-derived stem cells could be key to tailoring therapeutics to specific individuals, the authors noted.
Study findings were published Aug. 10 in Nature Neuroscience.
Sources
- Yale University, news release, Aug. 10, 2023
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Study Measures Mental Harms of Terrorism on Children With Autism
FRIDAY, July 12, 2024 -- The Oct. 7 terrorist attack on Israel has left children and parents with significant psychological scars, a new study shows. But families with a child...
Children With Autism Have Unique Microbiomes, Study Finds
TUESDAY, July 9, 2024 -- New research offers what could become a surprising way to diagnose whether a child has autism: Simply check the makeup of their gut microbiome. In a...
Younger Kids in Class Might Be Misdiagnosed With ADHD, Autism
FRIDAY, June 7, 2024 -- If your child is among the youngest in their school grade, it's more likely they'll be mistakenly identified by teachers as having ADHD or autism, a new...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.